![](data:image/png;base64,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)
Anticuerpos de SARS–CoV–2 en perros / Chiliquinga-Quinchiguano y col. ____________________________________________________________
4 de 5
Se debe destacar que ninguno de los 40 pacientes mostró durante
el periodo de estudio síntomas relacionados con el COVID–19,
representado por cuadros respiratorios o digestivos, a pesar que
estas relaciones íntimamente próximas entre los humanos enfermos
y sus mascotas, lo cual podría propiciar la transmisión zoonotica. Así
mismo, no se presentó correlación estadística entre los resultados
de Ig y los valores de TGP y TGO.
CONCLUSIONES
El estudio permite concluir, que se cuenta con una herramienta
sensible para el diagnóstico del COVID–19 en perros; no obstante, no
se tiene evidencia que exista la probabilidad de transmisión y contagio
desde el ser humano (dueño) a sus mascotas, y muchos menos de
manera de contagio zoonotico inverso, ya que el 95% de los perros
bajo estudio, resultó ser negativo a la prueba. El factor sexo y edad no
afectó signicativamente la probabilidad de padecer o no el COVID–19,
al igual que no existió correlación entre Ig y los valores de TGP y TGO.
Conicto de Intereses
Los autores certican que no existen conictos de interés en el
presente trabajo.
REFERENCIAS BIBLIOGRAFICAS
[1] ABDEL–MONEIM, A. S.; ABDELWHAB, E.M. Evidence for SARS–
CoV–2 Infection of Animal Hosts. Pathogens. 9(7): 529. 2020.
https://doi.org/gg4fzt.
[2] AGUILAR, N.; HERNÁNDEZ, A.; GUTIERREZ, C. Descripción del
virus Características del SARS–CoV–2 y sus mecanismos de
transmisión SARS–CoV–2. Rev. Latin. Infect. Pediatr. 33(3):
143–148. 2020. https://doi.org/h969.
[3] BOSCO–LAUTH, A.M.; HARTWIG, A.E.; PORTER, S.M.; GORDY,
P.W.; NEHRING, M.; BYAS, A.D.; VANDEWOUDE, S.; RAGAN, I.K.;
MAISON, R.M.; BOWEN, R.A. Experimental infection of domestic
dogs and cats with SARS–CoV–2: Pathogenesis, transmission,
and response to reexposure in cats. Proceed. Nation. Academy
Sci. 117(42): 26382–26388. 2020. https://doi.org/ghj9d7.
[4] CABRERA, A.; GONZÁLEZ–ÁLVAREZ, D.; GUTIÉRREZ, L.A.; DÍAZ,
F.J.; FORERO, D.; RODAS, J.D. Infección natural de SARS–CoV–2
en gatos y perros domésticos de humanos diagnosticados con
COVID–19 en el Valle de Aburrá, Antioquia. Biomed. 42: e6407. 2022.
[5] CALVET, G.A.; PEREIRA, S.A.; OGRZEWALSKA, M.; PAUVOLID–
CORRÊA, A.; RESENDE, P.C.; TASSINARI, W.S.; COSTA, A.P.; KEIDEL,
L.O.; DA ROCHA, A.S.B.; DA SILVA, M.F.B.; DOS SANTOS, S.A.; LIMA,
A.B.M.; DE MORAES, I.C.V.; MENDES–JUNIOR, A.A.V.; SOUZA,
T.D.C.; MARTINS, E.B.; ORNELLAS, R.O.; CORRÊA, M.L.; ANTONIO,
I.M.; GUARALDO, L.; MOTTA, F.D.C.; BRASIL, P.; SIQUEIRA, M,M,;
GREMIÃO, I.D.; MENEZES, R,C.. Investigation of SARS–CoV–2
infection in dogs and cats of humans diagnosed with COVID–19 in
Rio de Janeiro, Brazil. PLoS One. 16:e0250853. 2021.
[6] CENTER FOR DISEASE CONTROL AND PREVENTION (CDC–COVID–
19). Animals and COVID–19. 2020. Center for Disease Control
and Prevention (CDC). EUA. En línea: https://bit.ly/3AKt8CS.
02/04/2022.
[7] COHEN, J. From mice to monkeys, animals studied for
coronavirus answers Infected lab animals can assess drugs
and vaccines. Sci. 368: 221–222. 2020.
[8] COLINA, S.; ASPITIA, C.; NOGUEIRAS, J.; SERENA, M.; ECHEVERRIA,
M.; METZ, G. The third great leap: animal coronaviruses in Latin
America. Analecta Vet. 41(2): e059. 2021.
[9] CSISZAR, A.; JAKAB, F.; VALENCAK, T.G.; LANSZKI, Z.; TÓTH,
G.E.; KEMENESI, G.; TARANTINI, S.; FAZEKAS–PONGOR, V.;
UNGVARI, Z. Companion animals likely do not spread COVID–19
but may get infected themselves. GeroSci. 42(5): 1229–1236.
2020. https://doi.org/gk7d9s.
[10] DECARO, N.; BALBONI, A.; BERTOLOTTI, L.; MARTINO, P. A.;
MAZZEI, M.; MIRA, F.; AGNINI, U. SARS–CoV–2 Infection in Dogs
and Cats: Facts and Speculations. Frontiers in Vet. Sci. 8: 80.
2021. https://doi.org/h97b.
[11] FREULING, C M.; BREITHAUPT, A.; MÜLLER, T.; SEHL, J.; BALKEMA–
BUSCHMANN, A.; RISSMANN, M.; KLEIN, A.; WYLEZICH, C.; HÖPER,
D.; WERNIKE, K.; AEBISCHER, A.; HOFFMANN, D.; FRIEDRICHS,
V.; DORHOI, A.; GROSCHUP, M.H.; BEER, M.; ETTENLEITER, T.C.
Susceptibility of Raccoon Dogs for Experimental SARS–CoV–2
Infection. Emerg. Infect. Dis. 26(12): 2982. 2020. https://doi.
org/ffzf.
[12] FRITZ, M.; ROSOLEN, B.; KRAFFT, E.; BECQUART, P.; ELGUERO,
E.; VRATSKIKH, O.; DENOLLY, S.; BOSON, B.; VANHOMWEGEN,
J.; GOUILH, M. A.; KODJO, A.; CHIROUZE, C.; ROSOLEN, S.G.;
LEGROS, V.; LEROY, E.M. High prevalence of SARS–CoV–2
antibodies in pets from COVID–19+ households. One Health. 11:
100192. 2020. https://doi.org/gk7fbm.
[13] HOSSAIN, M.G.; JAVED, A.; AKTER, S.; SAHA, S. SARS–CoV–2
host diversity: An update of natural infections and experimental
evidence. J. Microbiol. Immunol. Infect. 54(2): 175–181. 2021.
https://doi.org/gg4s87.
[14] HU, B.; GUO, H.; ZHOU, P.; SHI, Z.L. Characteristics of SARS–
CoV–2 and COVID–19. Nat. Rev. Microbiol. 19: 141–154. 2021.
[15] KLAUS, J.; ZINI, E.; HARTMANN, K.; EGBERINK, H.; KIPAR, A.;
BERGMANN, M.; PALIZZOTTO, C.; ZHAO, S.; ROSSI, F.; FRANCO,
V.; PORPORATO, F.; HOFMANN–LEHMANN, R.; MELI, M.L. SARS–
CoV–2 Infection in Dogs and Cats from Southern Germany and
Northern Italy during the First Wave of the COVID–19 Pandemic.
Viruses. 13(8):1453. 2021. https://doi.org/h97h.
[16] LAIDOUDI, Y.; SEREME, Y.; MEDKOUR, H.; WATIER–GRILLOT, S.;
SCANDOLA, P.; GINESTA, J.; ANDRÉO, V.; LABARDE, C.; COMTET,
L.; POURQUIER, P.; RAOULT, D.; MARIÉ, J.L.; DAVOUST, B. SARS–
CoV–2 antibodies seroprevalence in dogs from France using
ELISA and an automated Western blotting assay. One Health. 13:
100293. 2021. https://doi.org/h97c.
[17] LAU, S.K.P.; LUK, H.K.H.; WONG, A.C.P.; LI, K.S.M.; ZHU, L.; HE,
Z., FUNG, J.; CHAN, T.T.Y.; FUNG, K.S.C.; WOO, P.C.Y. Possible
bat origin of Severe Acute Respiratory Syndrome Coronavirus
2. Emerg. Infect. Dis. 26: 1542–1547. 2020.
[18] MAGUIÑA–VARGAS, C.; GASTELO–ACOSTA, R.; TEQUEN–BERNILLA,
A. El nuevo Coronavirus y la pandemia del Covid–19. Rev. Med.
Herediana. 31(2): 125–131. 2020. https://doi.org/gh9h.